AMPE
Ampio Pharmaceuticals, Inc.
Price Chart
Latest Quote
$0.18
+0.00 (+0.00%)
Current Price
| Previous Close | $0.18 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 334 |
Stock Information
| Shares Outstanding | 1.14M |
| Total Debt | $451K |
| Cash Equivalents | $4.12M |
| Net Income | $-8.63M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $208K |
| EPS (TTM) | $-12.79 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-3.46M |
| Income | $-8.63M |
| Book/sh | $4.03 |
| Cash/sh | $3.63 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 2.12 |
| Current Ratio | 2.41 |
| Debt/Eq | 13.42 |
Returns & Margins
| ROA | -61.57% |
| ROE | -113.96% |
Ownership
| Institutional Ownership | 0.04% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.03 |
| P/B | 0.05 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.15 |
| SMA200 | $0.10 |
| RSI | nan |
| Shares Float | 1.12M |
| Short Float | 2.94% |
| Short Ratio | 0.31 |
| Volatility | 6.07 |
Performance History
| Week | +0.00% |
| Month | +3421.15% |
| Quarter | -37.41% |
| 6 Months | +3421.15% |
| YTD | +3421.15% |
| Year | +6003.33% |
| 3 Years | -96.95% |
| 5 Years | -99.97% |
| 10 Years | -99.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.18 | 0 |
| 2026-06-02 | $0.18 | 0 |
| 2026-06-01 | $0.18 | 0 |
| 2026-05-29 | $0.18 | 0 |
| 2026-05-28 | $0.18 | 0 |
| 2026-05-27 | $0.18 | 0 |
| 2026-05-26 | $0.18 | 0 |
| 2026-05-22 | $0.18 | 0 |
| 2026-05-21 | $0.18 | 0 |
| 2026-05-20 | $0.18 | 0 |
| 2026-05-19 | $0.18 | 0 |
| 2026-05-18 | $0.18 | 0 |
| 2026-05-15 | $0.18 | 0 |
| 2026-05-14 | $0.18 | 0 |
| 2026-05-13 | $0.18 | 0 |
| 2026-05-12 | $0.18 | 0 |
| 2026-05-11 | $0.18 | 0 |
| 2026-05-08 | $0.18 | 372 |
| 2026-05-07 | $0.64 | 1,553 |
| 2026-05-06 | $0.01 | 166 |
| 2026-05-05 | $0.01 | 0 |
| 2026-05-04 | $0.01 | 0 |
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
đ° Latest News
No news articles available at the moment. Check back later for updates on AMPE.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $9,518,000 | $20,382,000 | $20,571,000 |
| Other Income Expense | $538,000 | $3,825,000 | $3,492,000 |
| Other Non Operating Income Expenses | $594,000 | - | - |
| Net Non Operating Interest Income Expense | $348,000 | $220,000 | $4,000 |
| Operating Expense | $9,518,000 | $20,382,000 | $20,571,000 |
| General And Administrative Expense | $7,079,000 | $11,466,000 | $8,671,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Interest Income | $348,000 | $220,000 | $4,000 |
| Interest Income | $348,000 | $220,000 | $4,000 |
| Normalized Income | $-8,576,000 | $-20,162,000 | $-20,567,000 |
| Net Income From Continuing And Discontinued Operation | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Average Dilution Earnings | $0 | $-5,761,000 | - |
| Net Income Common Stockholders | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income Including Noncontrolling Interests | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income Continuous Operations | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Pretax Income | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Special Income Charges | $-56,000 | $-1,936,000 | $0 |
| Interest Income Non Operating | $348,000 | $220,000 | $4,000 |
| Operating Income | $-9,518,000 | $-20,382,000 | $-20,571,000 |
| Depreciation Amortization Depletion Income Statement | - | - | $24,000 |
| Depreciation And Amortization In Income Statement | - | - | $24,000 |
| Depreciation Income Statement | - | - | $24,000 |
| Per Share | |||
| Diluted EPS | - | $-29.32 | $-30.00 |
| Basic EPS | - | $-21.68 | $-27.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,340,000 | $-23,159,000 | $-22,969,000 |
| Total Unusual Items | $-56,000 | $3,825,000 | $3,492,000 |
| Total Unusual Items Excluding Goodwill | $-56,000 | $3,825,000 | $3,492,000 |
| Reconciled Depreciation | $122,000 | $1,048,000 | $1,094,000 |
| EBITDA (Bullshit earnings) | $-9,396,000 | $-19,334,000 | $-19,477,000 |
| EBIT | $-9,518,000 | $-20,382,000 | $-20,571,000 |
| Diluted NI Availto Com Stockholders | $-8,632,000 | $-22,098,000 | $-17,075,000 |
| Gain On Sale Of Ppe | $-56,000 | $0 | $0 |
| Impairment Of Capital Assets | $0 | $1,936,000 | $0 |
| Research And Development | $2,439,000 | $8,916,000 | $11,900,000 |
| Selling General And Administration | $7,079,000 | $11,466,000 | $8,671,000 |
| Other Gand A | $4,591,000 | $7,731,000 | $3,236,000 |
| Insurance And Claims | $964,000 | $1,124,000 | $1,186,000 |
| Salaries And Wages | $1,524,000 | $2,611,000 | $4,249,000 |
| Diluted Average Shares | - | $753,615 | $683,210 |
| Basic Average Shares | - | $753,615 | $664,330 |
| Gain On Sale Of Security | - | $5,761,000 | $3,492,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $3,360,000 | $11,789,000 | $27,284,000 |
| Total Assets | $5,736,000 | $13,588,000 | $38,825,000 |
| Total Non Current Assets | $0 | $259,000 | $3,193,000 |
| Current Assets | $5,736,000 | $13,329,000 | $35,632,000 |
| Other Current Assets | $342,000 | $642,000 | $549,000 |
| Current Deferred Assets | $136,000 | $0 | - |
| Prepaid Assets | $249,000 | $34,000 | $1,119,000 |
| Receivables | $920,000 | $0 | $16,000 |
| Other Receivables | $920,000 | - | $16,000 |
| Cash Cash Equivalents And Short Term Investments | $4,089,000 | $12,653,000 | $33,892,000 |
| Cash And Cash Equivalents | $4,089,000 | $12,653,000 | $33,892,000 |
| Inventory | - | $0 | $72,000 |
| Debt | |||
| Total Debt | $274,000 | $614,000 | $925,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $274,000 | $614,000 |
| Current Debt And Capital Lease Obligation | $274,000 | $340,000 | $311,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $2,376,000 | $1,799,000 | $11,541,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $607,000 | $6,419,000 |
| Derivative Product Liabilities | $0 | $44,000 | $5,805,000 |
| Current Liabilities | $2,376,000 | $1,192,000 | $5,122,000 |
| Payables And Accrued Expenses | $2,102,000 | $709,000 | $4,422,000 |
| Payables | $834,000 | $249,000 | $427,000 |
| Other Payable | $62,000 | - | - |
| Total Tax Payable | $22,000 | $152,000 | - |
| Accounts Payable | $750,000 | $97,000 | $427,000 |
| Equity | |||
| Common Stock Equity | $3,360,000 | $11,789,000 | $27,284,000 |
| Total Equity Gross Minority Interest | $3,360,000 | $11,789,000 | $27,284,000 |
| Stockholders Equity | $3,360,000 | $11,789,000 | $27,284,000 |
| Retained Earnings | $-242,527,000 | $-233,939,000 | $-217,602,000 |
| Other | |||
| Ordinary Shares Number | $833,430 | $755,143 | $11,366,269 |
| Share Issued | $833,430 | $755,143 | $11,366,269 |
| Tangible Book Value | $3,360,000 | $11,789,000 | $27,284,000 |
| Invested Capital | $3,360,000 | $11,789,000 | $27,284,000 |
| Working Capital | $3,360,000 | $12,137,000 | $30,510,000 |
| Capital Lease Obligations | $274,000 | $614,000 | $925,000 |
| Total Capitalization | $3,360,000 | $11,789,000 | $27,284,000 |
| Additional Paid In Capital | $245,887,000 | $245,728,000 | $244,884,000 |
| Capital Stock | $0 | $0 | $2,000 |
| Common Stock | $0 | $0 | $2,000 |
| Preferred Stock | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $274,000 | $614,000 |
| Current Capital Lease Obligation | $274,000 | $340,000 | $311,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $143,000 | $389,000 |
| Current Accrued Expenses | $1,268,000 | $460,000 | $3,995,000 |
| Net PPE | $0 | $259,000 | $3,193,000 |
| Accumulated Depreciation | $0 | $-9,245,000 | $-8,234,000 |
| Gross PPE | $0 | $9,504,000 | $11,427,000 |
| Leases | $0 | $4,965,000 | $6,075,000 |
| Machinery Furniture Equipment | $0 | $4,539,000 | $5,352,000 |
| Properties | $0 | $0 | $0 |
| Long Term Provisions | - | $289,000 | - |
| Other Properties | - | - | $238,000 |
| Other Inventories | - | - | $72,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-8,564,000 | $-21,128,000 | $-14,186,000 |
| Operating Activities | |||
| Operating Cash Flow | $-8,564,000 | $-21,128,000 | $-14,089,000 |
| Cash Flow From Continuing Operating Activities | $-8,564,000 | $-21,128,000 | $-14,089,000 |
| Operating Gains Losses | $56,000 | $-5,761,000 | $-3,492,000 |
| Investing Activities | |||
| Investing Cash Flow | $0 | $0 | $-97,000 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-97,000 |
| Capital Expenditure | - | - | $-97,000 |
| Financing Activities | |||
| Issuance Of Capital Stock | $98,000 | $0 | $33,012,000 |
| Financing Cash Flow | $0 | $-111,000 | $30,732,000 |
| Cash Flow From Continuing Financing Activities | $0 | $-111,000 | $30,732,000 |
| Net Other Financing Charges | $-98,000 | $-111,000 | $-2,514,000 |
| Net Common Stock Issuance | $98,000 | $0 | $33,012,000 |
| Common Stock Issuance | $98,000 | $0 | $33,012,000 |
| Repurchase Of Capital Stock | - | - | $-186,000 |
| Other | |||
| End Cash Position | $4,089,000 | $12,653,000 | $33,892,000 |
| Beginning Cash Position | $12,653,000 | $33,892,000 | $17,346,000 |
| Changes In Cash | $-8,564,000 | $-21,239,000 | $16,546,000 |
| Change In Working Capital | $15,000 | $-2,974,000 | $2,580,000 |
| Change In Other Current Liabilities | $-265,000 | $-79,000 | $-89,000 |
| Change In Payables And Accrued Expense | $1,251,000 | $-3,959,000 | $3,262,000 |
| Change In Prepaid Assets | $-51,000 | $1,064,000 | $-593,000 |
| Change In Receivables | $-920,000 | $0 | - |
| Other Non Cash Items | $-284,000 | $7,000 | $80,000 |
| Stock Based Compensation | $159,000 | $953,000 | $2,724,000 |
| Asset Impairment Charge | $0 | $1,936,000 | $0 |
| Depreciation Amortization Depletion | $122,000 | $1,048,000 | $1,094,000 |
| Depreciation And Amortization | $122,000 | $1,048,000 | $1,094,000 |
| Gain Loss On Sale Of PPE | $56,000 | $0 | $0 |
| Net Income From Continuing Operations | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Proceeds From Stock Option Exercised | - | $0 | $234,000 |
| Net PPE Purchase And Sale | - | $0 | $-97,000 |
| Purchase Of PPE | - | $0 | $-97,000 |
| Gain Loss On Investment Securities | - | $-5,761,000 | $-3,492,000 |
| Common Stock Payments | - | - | $-186,000 |
Fetched: 2026-02-02